SciELO - Scientific Electronic Library Online

 
vol.141 número5Características clínicas y evolución de pacientes con SIDA y dolor abdominal agudoRadiocirugía estereotáxica con acelerador lineal (LINAC): Informe de la experiencia técnica en el manejo de 100 casos en el Hospital General de México índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Gaceta médica de México

versão On-line ISSN 2696-1288versão impressa ISSN 0016-3813

Resumo

ARELLANES-GARCIA, Lourdes; PADILLA-AGUILAR, Gonzalo; NAVARRO-LOPEZ, Patricia  e  ESPINOZA-MARTINEZ, Cynthia. Efficacy of prednisolone and rimexolone in HLA-B27 positive patients with acute anterior uveitis. Gac. Méd. Méx [online]. 2005, vol.141, n.5, pp.363-366. ISSN 2696-1288.

Purpose: To compare the efficacy and safety of prednisolone acetate 1 % vs. rimexolone 1 % ophthalmic suspension in the treatment of acute anterior uveitis (AAU) in HLA-B27+ patients. Methods: Sixty-eight AAU HLA-B27+ patients were randomly selected for treatment with prednisolone acetate 1% or Rimexolone 1%. All patients showed mild to moderate anterior chamber inflammation. This was a prospective, randomized, double blind, clinical trial. Results: There was no statistically significant difference between both groups when anterior chamber cells were measured. In the rimexolone group, flare diminished since the first week. In both groups the intraocular pressure (IOP) raised since the first week; the increase washighly significant in the rimexolone group. Final intraocular pressure was higher in the prednisolone group. Conclusion: Rimexolone 1 % is as effective as prednisolone acetate 1% in the treatment of mild to moderate AAU HLA B27+. IOP increased in both groups, but this variation was not clinically significant.

Palavras-chave : Anterior uveitis; flare; cells; rimexolone; prednisolone acetate; HLA-B27; intraocular pressure.

        · resumo em Espanhol     · texto em Espanhol

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons